Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.
Antibiotic resistance
Health equity
hospital-acquired infections
low-resource countries
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
pubmed:
18
1
2022
medline:
11
2
2022
entrez:
17
1
2022
Statut:
ppublish
Résumé
Antimicrobial resistance (AMR) and hospital-acquired infections (HAIs) are global health challenges. The burden of antibiotic resistance in HAIs is still unclear in low- and lower-middle-income countries (L-LMICs). This study summarizes recent data on antibiotic resistance in priority HAIs (ESKAPE-E) in L-LMICs and compares them with data from high-income countries (HICs). EMBASE, Web of Science, and Global Index Medicus were searched for studies on AMR patterns in HAIs published from 01/2010 to 10/2020. Random-effects meta-analyses were performed to obtain pooled estimates. In total, 163 eligible studies were included in the review and meta-analysis. The pooled methicillin resistance proportion in
Identifiants
pubmed: 35034585
doi: 10.1080/22221751.2022.2030196
pmc: PMC8820817
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-451Commentaires et corrections
Type : CommentIn
Références
Afr J Emerg Med. 2018 Sep;8(3):110-117
pubmed: 30456159
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
J Glob Antimicrob Resist. 2019 Dec;19:313-316
pubmed: 31176071
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Int J Infect Dis. 2013 Dec;17(12):e1225-8
pubmed: 24094525
Front Pharmacol. 2020 Oct 30;11:585553
pubmed: 33192526
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S128-S134
pubmed: 30423045
Braz J Microbiol. 2015 Jul 01;46(3):777-83
pubmed: 26413060
J Clin Microbiol. 2019 May 24;57(6):
pubmed: 30971460
PLoS One. 2019 May 8;14(5):e0215666
pubmed: 31067232
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Euro Surveill. 2021 Nov;26(45):
pubmed: 34763754
Lancet Infect Dis. 2021 Jan;21(1):107-115
pubmed: 32717205
J Hosp Infect. 2019 Jan;101(1):60-68
pubmed: 29730140
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Ann Afr Med. 2017 Jul-Sep;16(3):107-113
pubmed: 28671150
Antimicrob Resist Infect Control. 2014 May 14;3:17
pubmed: 24883183
Mediterr J Hematol Infect Dis. 2013 Sep 02;5(1):e2013056
pubmed: 24106606
J Infect Public Health. 2020 Apr;13(4):637-643
pubmed: 31537511
J Hosp Infect. 2020 Apr 10;:
pubmed: 32283173
Cureus. 2021 Oct 20;13(10):e18925
pubmed: 34812309
J Hosp Infect. 2021 Feb;108:94-103
pubmed: 33271215
Intensive Care Med. 2020 Aug;46(8):1536-1551
pubmed: 32591853
Open Access Maced J Med Sci. 2019 Jun 14;7(11):1744-1749
pubmed: 31316652
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Infect Drug Resist. 2021 Jun 10;14:2179-2181
pubmed: 34140786
Euro Surveill. 2018 Oct;23(42):
pubmed: 30352640
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
Emerg Microbes Infect. 2020 Dec;9(1):1180-1193
pubmed: 32498615